Lingbao Gold Group Company Ltd
HKEX:3330
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lingbao Gold Group Company Ltd
HKEX:3330
|
CN |
|
M
|
Medy Tox Inc
KOSDAQ:086900
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Lingbao Gold Group Company Ltd's stock price target?
Not Available
Lingbao Gold Group Company Ltd doesn't have any price targets made by Wall Street professionals.
What is Lingbao Gold Group Company Ltd's Revenue forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Lingbao Gold Group Company Ltd's revenue is
6%.
The projected
CAGR
for the next 3 years is
22%.
What is Lingbao Gold Group Company Ltd's Operating Income forecast?
Projected CAGR
31%
For the last 13 years the
compound annual growth rate for
Lingbao Gold Group Company Ltd's operating income is
4%.
The projected
CAGR
for the next 3 years is
31%.
What is Lingbao Gold Group Company Ltd's Net Income forecast?
Projected CAGR
37%
For the last 13 years the
compound annual growth rate for
Lingbao Gold Group Company Ltd's net income is
6%.
The projected
CAGR
for the next 3 years is
37%.
